| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9179 |
| Human Intestinal Absorption | HIA+ | 0.9318 |
| Caco-2 Permeability | Caco2+ | 0.6414 |
| P-glycoprotein Substrate | Non-substrate | 0.5701 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6465 |
| Non-inhibitor | 0.8722 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8791 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9132 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8782 |
| CYP450 2D6 Substrate | Non-substrate | 0.8958 |
| CYP450 3A4 Substrate | Non-substrate | 0.6139 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5665 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7159 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9161 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5558 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8929 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5565 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9765 |
| Non-inhibitor | 0.8527 |
| AMES Toxicity | Non AMES toxic | 0.8552 |
| Carcinogens | Non-carcinogens | 0.7105 |
| Fish Toxicity | High FHMT | 0.8900 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9347 |
| Honey Bee Toxicity | High HBT | 0.5169 |
| Biodegradation | Ready biodegradable | 0.6618 |
| Acute Oral Toxicity | IV | 0.6070 |
| Carcinogenicity (Three-class) | Non-required | 0.5996 |